Stocklytics Platform
Asset logo for symbol INVA
Innoviva
INVA58
$17.78arrow_drop_down0.05%-$0.00
Asset logo for symbol INVA
INVA58

$17.78

arrow_drop_down0.05%
Key Stats
Open$17.80
Prev. Close$17.79
EPS0.80
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range17.26
19.00
52 Week Range12.22
21.22
Ratios
EPS0.80
Fundamentals
Payout Ratio-
Industry average yield2.90%
Last Dividend pay dateSep 30, 2015
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

INVA-
US Healthcare Sector-
US Market-
warning

INVA / Market

INVA lose to the US Market which returned 1.00% over the last twenty four hours.
warning

INVA / Healthcare Sector

INVA lose to the US Healthcare sector which returned 2.95% over the last twenty four hours.

Innoviva (INVA) Statistics

Innoviva Inc (INVA) stock statistics provide key insights into the performance and trends of the company's stock. These statistics include various metrics such as valuation metrics, fundamentals, stock performance compared to the sector, revenue per share, enterprise to EBITDA ratio, profit margin, total debt, and gross profit.
Valuation metrics for Innoviva Inc (INVA) can help investors assess the company's market value. These metrics may include price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, price-to-book (P/B) ratio, and dividend yield. By analyzing these metrics, investors can determine whether the stock is undervalued or overvalued.
add Innoviva  to watchlist

Keep an eye on Innoviva

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How much debt does Innoviva (INVA) have?

Innoviva (INVA) has a total debt of $521.96M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$4.66M.
help

What is the EBITDA of Innoviva (INVA) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Innoviva (INVA) is $168.02M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How has Innoviva (INVA) stock's performance compared to its sector and the market over the past year?

Over the past year, Innoviva (INVA) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.34%, Innoviva has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 47.67%, it has fallen short of the market average. This comparison highlights Innoviva 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Innoviva (INVA) stock?

The PE (Price to Earnings) ratio of Innoviva (INVA) is currently 22.23. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Innoviva (INVA) stock?

The Earnings Per Share (EPS) for Innoviva (INVA), calculated on a diluted basis, is $0.8. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Innoviva (INVA) stock?

The operating margin for Innoviva (INVA) is 48.31%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

Take Your Investments to a Whole New Level